PAYSAFE
19.10.2021 10:02:14 CEST | Business Wire | Press release
Leading integrated payments platform, Paysafe (NYSE: PSFE), today announces that it has extended its partnership with payments provider ZEN.COM. Paysafe’s eCash solution, Paysafecash, can now be used by individual customers as well as business clients across 25 countries in Europe to make fast and secure cash deposits into ZEN.COM’s virtual wallets.
After selecting Paysafecash as the top up method in the ZEN.COM mobile app, the customer chooses how much cash to deposit into their account and generates a unique barcode for the transaction. The barcode doesn't have to be used straight away – the customer has 72 hours to proceed further. Within this time, the customer can go to a nearby payment point, scan the barcode at the point of sale terminal and make the payment in cash. The deposited amount will be credited to ZEN.COM’s virtual wallet within minutes. The wallet can manage accounts in 30 currencies and can be used for currency exchange and as a payment card. What’s more, thanks to an integrated IBAN number, the wallet complements the traditional bank account and enables money transfers.
ZEN.COM’s integration of Paysafecash provides a highly sought-after cash loading option for digital banking customers in the following 25 countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and the UK.
Today’s announcement is the latest development in an ongoing collaboration between the two companies. ZEN.COM’s business clients already have the option of accepting payments via Paysafe’s leading prepaid solution paysafecard and digital wallet Skrill. Furthermore, paysafecard has been enabled for wallet loading and there are also plans for further integrations of Paysafe’s payments solutions.
Michał Bogusławski, Commercial Director of ZEN.COM commented, “The financial services industry and the consumer needs within it are changing on a daily basis. However, the general trends give us a clear indication that consumers are looking for simplicity in addition to security. In order to fulfil these needs, innovation and cooperation between industry players is key. At ZEN.COM, we strive to cater to both businesses and customers by providing them with an all-in-one solution. Our cooperation with Paysafe, our valued partner over many years, benefits multiple audiences by allowing us to provide merchants with a wider variety of payment methods and enable customers to use their preferred payment method. As an agile and trustworthy partner, Paysafe is a pleasure to work with.”
Udo Müller, CEO of Paysafe’s eCash division, which encompasses paysafecard and Paysafecash , added: “I’m excited about extending our partnership with ZEN.COM to provide a cash-based deposit functionality with Paysafecash. Our eCash network is extremely well established and continually expanding, making this a very convenient and accessible wallet-loading option for ZEN.COM’s cash-based customers, especially as cash remains a cornerstone of the payment landscape in many of these countries.”
~ENDS~
About Paysafecash
Paysafecash, from leading specialised payments platform Paysafe, is an eCash payment method for customers who want to pay online easily and safely using cash. Available in nearly 30 countries, Paysafecash makes online transactions possible for customers, who do not have a debit or credit card, or who do not want to use them online. Payments are made by generating a barcode during the online checkout, which can then be scanned and paid for in person at one of more than 190,000 payment points. Paysafecash was launched in 2018 by the same Paysafe team who created the award-winning, prepaid cash solution paysafecard in 2000. A market leader in eCash payment solutions, paysafecard allows customers to buy prepaid vouchers that they can then redeem online.
About Paysafe Limited
Paysafe Limited (“Paysafe”) (NYSE: PSFE) (PSFE.WS) is a leading specialized payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through industry-leading capabilities in payment processing, digital wallet, and online cash solutions. With over 20 years of online payment experience, an annualized transactional volume of US $100 billion in 2020, and approximately 3,400 employees located in 12+ global locations, Paysafe connects businesses and consumers across 70 payment types in over 40 currencies around the world. Delivered through an integrated platform, Paysafe solutions are geared toward mobile-initiated transactions, real-time analytics and the convergence between brick-and-mortar and online payments. Further information is available at www.paysafe.com
.
About ZEN.COM
ZEN.COM is an innovative payment model that debuted in November 2020 in response to the challenges posed by the growing e-commerce market. By changing the approach to online trade and paying for purchases, it aims to support both merchants and consumers. As a financial institution, ZEN.COM holds an e-money license under the supervision of the Central Bank of Lithuania, and the European Banking Authority has approved the company's operations throughout the European Economic Area (EEA). As a result, fintech’s services are available across 31 European countries. ZEN.COM has also earned the trust of leading payment institutions. The fintech is a direct partner of many payment organizations, such as Mastercard, VISA, American Express, Union Pay, and in cooperation with global and local payment methods strives to meet the most demanding expectations of users. The company was founded by Dawid Rożek, creator of the international success of the auction site for players with 20 million customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005105/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
